Back to ALNY

ALNYLAM PHARMACEUTICALS, INC. EPS (Diluted) 2019-2025 | ALNY

Beta

What is eps (diluted)?

Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.

What is ALNYLAM PHARMACEUTICALS, INC.'s current eps (diluted)?

ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual eps (diluted) for 2025 was $2.33, a 206.88% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. eps (diluted) for the quarter ending September 30, 2025 was $1.84.

What was ALNYLAM PHARMACEUTICALS, INC.'s eps (diluted) in 2024?

ALNYLAM PHARMACEUTICALS, INC. annual eps (diluted) for 2024 was $-2.18, a 38.07% increase from 2023.

What was ALNYLAM PHARMACEUTICALS, INC.'s eps (diluted) in 2023?

ALNYLAM PHARMACEUTICALS, INC. annual eps (diluted) for 2023 was $-3.52, a 62.15% increase from 2022.

EPS (Diluted) History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Growing
CAGRN/A
FY2020
$-7.46
→
FY2025
$2.33
19202122232425
5 years selected
EPS (Diluted) History
PeriodValueChangeSource
FY2025$2.33+206.9%10-K
FY2024$-2.18+38.1%10-K
FY2023$-3.52+62.2%10-K
FY2022$-9.30-29.2%10-K
FY2021$-7.20+3.5%10-K
FY2020$-7.46+8.0%10-K
FY2019$-8.11-10-K
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →